scholarly journals myo-inositol transport and metabolism in fetal-bovine aortic endothelial cells

1993 ◽  
Vol 295 (3) ◽  
pp. 863-869 ◽  
Author(s):  
G T Berry ◽  
R A Johanson ◽  
J E Prantner ◽  
B States ◽  
J R Yandrasitz

The myo-inositol transport system in confluent fetal-bovine aortic endothelial cells was characterized after 7-10 days in subculture, at which time the myo-inositol levels and rates of myo-[2-3H]-inositol uptake and incorporation into phospholipid had reached steady state. Kinetic analysis indicated that the uptake occurred by both a high-affinity transport system with an apparent Kt of 31 microM and Vmax. of 45 pmol/min per mg of protein, and a non-saturable low-affinity system. Uptake was competitively inhibited by phlorhizin, with a Ki of 50 microM; phloretin was a non-competitive inhibitor, with half-maximal inhibition between 0.2 and 0.5 mM. Glucose was a weak competitive inhibitor, with a Ki of 37 mM; galactose failed to inhibit uptake. A weak dependence on Na+ for the initial rate of uptake was observed at 11 microM myo-inositol. When fetal-bovine-serum (FBS)-supplemented medium, which contained 225 microM myo-inositol, was used, the cells contained about 200 nmol of myo-inositol/mg of DNA. With adult-bovine-serum (ABS)-supplemented medium, which contained 13 microM myo-inositol, the cells contained about 110 nmol/mg of DNA. Transport of 11 microM myo-[2-3]inositol was 18 and 125 pmol/min per mg of DNA for cells grown in FBS and ABS respectively. Kinetic analysis showed that for the cells grown in FBS the Vmax. of the high-affinity system was decreased by 64%, whereas the Kt remained essentially unchanged. Increased cell myo-inositol levels were not associated with an increased rate of phosphatidylinositol synthesis. After prolonged exposure of fetal endothelial cells to a myo-inositol concentration which approximated to a high fetal as opposed to a low adult blood level, cell myo-inositol levels doubled and high-affinity transport underwent down-regulation.

1991 ◽  
Vol 207 (2) ◽  
pp. 149-155 ◽  
Author(s):  
Thérèse M. Keravis ◽  
Herrade Nehlig ◽  
Marie-Françoise Delacroix ◽  
Domenico Regoli ◽  
C. Robin Hiley ◽  
...  

1998 ◽  
Vol 83 (11) ◽  
pp. 1088-1096 ◽  
Author(s):  
Ken-ichiro Kikuta ◽  
Tatsuya Sawamura ◽  
Soichi Miwa ◽  
Nobuo Hashimoto ◽  
Tomoh Masaki

1983 ◽  
Vol 49 (02) ◽  
pp. 132-137 ◽  
Author(s):  
A Eldor ◽  
G Polliack ◽  
I Vlodavsky ◽  
M Levy

SummaryDipyrone and its metabolites 4-methylaminoantipyrine, 4-aminoantipyrine, 4-acetylaminoantipyrine and 4-formylaminoan- tipyrine inhibited the formation of thromboxane A2 (TXA2) during in vitro platelet aggregation induced by ADP, epinephrine, collagen, ionophore A23187 and arachidonic acid. Inhibition occurred after a short incubation (30–40 sec) and depended on the concentration of the drug or its metabolites and the aggregating agents. The minimal inhibitory concentration of dipyrone needed to completely block aggregation varied between individual donors, and related directly to the inherent capacity of their platelets to synthesize TXA2.Incubation of dipyrone with cultured bovine aortic endothelial cells resulted in a time and dose dependent inhibition of the release of prostacyclin (PGI2) into the culture medium. However, inhibition was abolished when the drug was removed from the culture, or when the cells were stimulated to produce PGI2 with either arachidonic acid or ionophore A23187.These results indicate that dipyrone exerts its inhibitory effect on prostaglandins synthesis by platelets or endothelial cells through a competitive inhibition of the cyclooxygenase system.


1990 ◽  
Vol 265 (13) ◽  
pp. 7195-7201
Author(s):  
B A Lipton ◽  
E P Davidson ◽  
B H Ginsberg ◽  
M A Yorek

1996 ◽  
Vol 18 (3) ◽  
pp. 193-206 ◽  
Author(s):  
Johannes M�thing ◽  
Sevim Duvar ◽  
Susann Nerger ◽  
Heino B�ntemeyer ◽  
J�rgen Lehmann

Sign in / Sign up

Export Citation Format

Share Document